Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 218 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 2683 results:
Author Title [ Type(Desc)] Year
Journal Article
J. Wilding, Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., Clauson, P., Fenici, P., Hammar, N., and Medina, J., Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink, BMC Med, vol. 16, p. 116, 2018.
D. Prieto-Alhambra, Javaid, M. K., Maskell, J., Judge, A., Nevitt, M., Cooper, C., and Arden, N. K., Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study, Ann Rheum Dis, vol. 70, pp. 134-8, 2011.
T. Kendrick, Stuart, B., Newell, C., Geraghty, A. W., and Moore, M., Changes in rates of recorded depression in English primary care 2003-2013: Time trend analyses of effects of the economic recession, and the GP contract quality outcomes framework (QOF), J Affect Disord, vol. 180, pp. 68-78, 2015.
E. Setakis, Leufkens, H. G., and van Staa, T. P., Changes in the characteristics of patients prescribed selective cyclooxygenase 2 inhibitors after the 2004 withdrawal of rofecoxib, Arthritis Rheum, vol. 59, pp. 1105-11, 2008.
J. K. Quint, Millett, E. R., Joshi, M., Navaratnam, V., Thomas, S. L., Hurst, J. R., Smeeth, L., and Brown, J. S., Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study, Eur Respir J, vol. 47, pp. 186-93, 2016.
S. Chowienczyk, Price, S., and Hamilton, W., Changes in the presenting symptoms of lung cancer from 2000-2017: a serial cross-sectional study of observational records in UK primary care, Br J Gen Pract, 2020.
C. S. Zin, Chen, L. C., and Knaggs, R. D., Changes in trends and pattern of strong opioid prescribing in primary care, Eur J Pain, vol. 18, pp. 1343-51, 2014.
A. V. Gayle, Axson, E. L., Bloom, C. I., Navaratnam, V., and Quint, J. K., Changing causes of death for patients with chronic respiratory disease in England, 2005-2015, Thorax, 2019.
H. P. Booth, Khan, O., Fildes, A., Prevost, A. T., Reddy, M., Charlton, J., and Gulliford, M. C., Changing Epidemiology of Bariatric Surgery in the UK: Cohort Study Using Primary Care Electronic Health Records, Obes Surg, vol. 26, pp. 1900-5, 2016.
S. V. Ramagopalan, Carroll, R., Ulvestad, M., Mehmud, F., and Alikhan, R., The changing face of venous thromboembolism management in England, Future Cardiol, 2019.
R. Ackers, Besag, F. M., Wade, A., Murray, M. L., and Wong, I. C., Changing trends in antiepileptic drug prescribing in girls of child-bearing potential, Arch Dis Child, vol. 94, pp. 443-7, 2009.
S. Wilkinson, Douglas, I., Stirnadel-Farrant, H., Fogarty, D., Pokrajac, A., Smeeth, L., and Tomlinson, L., Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017, BMJ Open, vol. 8, p. e022768, 2018.
C. J. Edwards, Arden, N. K., Fisher, D., Saperia, J. C., Reading, I., van Staa, T. P., and Cooper, C., The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database, Rheumatology (Oxford), vol. 44, pp. 1394-8, 2005.
R. B. Weinstein, Ryan, P. B., Berlin, J. A., Schuemie, M. J., Swerdel, J., and Fife, D., Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen, Drug Saf, 2020.
R. B. Weinstein, Ryan, P., Berlin, J. A., Matcho, A., Schuemie, M., Swerdel, J., Patel, K., and Fife, D., Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications, Drug Saf, vol. 40, pp. 1279-1292, 2017.
T. M. MacDonald, Morant, S. V., Goldstein, J. L., Burke, T. A., and Pettitt, D., Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs, Gut, vol. 52, pp. 1265-70, 2003.
L. Kalilani, Friesen, D., Boudiaf, N., and Asgharnejad, M., The characteristics and treatment patterns of patients with Parkinson's disease in the United States and United Kingdom: A retrospective cohort study, PLoS One, vol. 14, p. e0225723, 2019.
H. R. Whittaker, Pimenta, J. M., Jarvis, D., Kiddle, S. J., and Quint, J. K., Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease, Int J Chron Obstruct Pulmon Dis, vol. 15, pp. 3079-3091, 2020.
Y. S. Punekar, Landis, S. H., Wurst, K., and Le, H., Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care, Respir Res, vol. 16, p. 141, 2015.
S. Ramtoola, Nyeland, M. E., Jacobsen, J., Ploug, U. J., Kragh, N., and Zimmermann, E., Characteristics of newly diagnosed adults with type 1 diabetes in the UK and evolution of glycaemic control, body mass index and Charlson comorbidity index over the first 5 years after diagnosis, Prim Care Diabetes, 2019.
Y. Zhu, Edwards, D., Mant, J., Payne, R. A., and Kiddle, S., Characteristics, service use and mortality of clusters of multimorbid patients in England: a population-based study, BMC Med, vol. 18, p. 78, 2020.
A. Ruigomez, Rodriguez, L. A., Wallander, M. A., Johansson, S., and Jones, R., Chest pain in general practice: incidence, comorbidity and mortality, Fam Pract, vol. 23, pp. 167-74, 2006.
A. Ruigomez, Masso-Gonzalez, E. L., Johansson, S., Wallander, M. A., and Garcia-Rodriguez, L. A., Chest pain without established ischaemic heart disease in primary care patients: associated comorbidities and mortality, Br J Gen Pract, vol. 59, pp. e78-86, 2009.
S. L. Thomas, Minassian, C., Ganesan, V., Langan, S. M., and Smeeth, L., Chickenpox and risk of stroke: a self-controlled case series analysis, Clin Infect Dis, vol. 58, pp. 61-8, 2014.
C. H. van Jaarsveld and Gulliford, M. C., Childhood obesity trends from primary care electronic health records in England between 1994 and 2013: population-based cohort study, Arch Dis Child, vol. 100, pp. 214-9, 2015.
J. M. Burnham, Shults, J., Weinstein, R., Lewis, J. D., and Leonard, M. B., Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database, Ann Rheum Dis, vol. 65, pp. 1074-9, 2006.
T. P. van Staa, Cooper, C., Leufkens, H. G., and Bishop, N., Children and the risk of fractures caused by oral corticosteroids, J Bone Miner Res, vol. 18, pp. 913-8, 2003.
den C. Heijer, Hoebe, C., Driessen, J. H., Wolffs, P., van den Broek, I., Hoenderboom, B., Williams, R., de Vries, F., and Dukers-Muijrers, N., Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients, Clinical Infectious Diseases, 2019.
T. Shao and Yang, Y. X., Cholecystectomy and the risk of colorectal cancer, Am J Gastroenterol, vol. 100, pp. 1813-20, 2005.
L. E. Derby, Jick, H., Henry, D. A., and Dean, A. D., Cholestatic hepatitis associated with flucloxacillin, Med J Aust, vol. 158, pp. 596-600, 1993.
S. Rietbrock, Heeley, E., Plumb, J., and Van Staa, T., Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme, Am Heart J, vol. 156, pp. 57-64, 2008.
A. Dregan, Charlton, J., Chowienczyk, P., and Gulliford, M. C., Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study, Circulation, vol. 130, pp. 837-44, 2014.
M. Iwagami, Caplin, B., Smeeth, L., Tomlinson, L. A., and Nitsch, D., Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data, Br J Gen Pract, vol. 68, pp. e512-e523, 2018.
A. D. Morgan, Rothnie, K. J., Bhaskaran, K., Smeeth, L., and Quint, J. K., Chronic obstructive pulmonary disease and the risk of 12 cardiovascular diseases: a population-based study using UK primary care data, Thorax, vol. 73, pp. 877-879, 2018.
C. Schneider, Bothner, U., Jick, S. S., and Meier, C. R., Chronic obstructive pulmonary disease and the risk of cardiovascular diseases, Eur J Epidemiol, vol. 25, pp. 253-60, 2010.
S. Menon, Nightingale, P., and Trudgill, N., Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study, J Clin Gastroenterol, 2019.
L. A. Garcia Rodriguez, Wallander, M. A., Tolosa, L. B., and Johansson, S., Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors, Copd, vol. 6, pp. 369-79, 2009.
Y. X. Yang, Hennessy, S., Propert, K., Hwang, W. T., Sedarat, A., and Lewis, J. D., Chronic proton pump inhibitor therapy and the risk of colorectal cancer, Gastroenterology, vol. 133, pp. 748-54, 2007.
S. L. Stevens, Stevens, R. J., Hobbs, F. D., and Lasserson, D. S., Chronic renal disease is not chronic kidney disease: implications for use of the QRISK and Joint British Societies risk scores, Fam Pract, vol. 33, pp. 57-60, 2016.
Y. X. Yang, Hennessy, S., Propert, K., Hwang, W. T., Sarkar, M., and Lewis, J. D., Chronic statin therapy and the risk of colorectal cancer, Pharmacoepidemiol Drug Saf, vol. 17, pp. 869-76, 2008.
V. Kuan, Denaxas, S., A Izquierdo, G. -, Direk, K., Bhatti, O., Husain, S., Sutaria, S., Hingorani, M., Nitsch, D., Parisinos, C. A., Lumbers, T., Mathur, R., Sofat, R., Casas, J. P., Wong, I. C. K., Hemingway, H., and Hingorani, A. D., A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service, The Lancet Digital Health, 2019.
M. A. Hernan, Jick, S. S., Logroscino, G., Olek, M. J., Ascherio, A., and Jick, H., Cigarette smoking and the progression of multiple sclerosis, Brain, vol. 128, pp. 1461-5, 2005.
S. Jick, Ciprofloxacin safety in a pediatric population, Pediatr Infect Dis J, vol. 16, pp. 130-3; discussion 133-4, 160-2, 1997.
H. I. McDonald, Thomas, S. L., Millett, E. R., and Nitsch, D., CKD and the risk of acute, community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using electronic health records, Am J Kidney Dis, vol. 66, pp. 60-8, 2015.
A. I. B. Kurdi, Elliott, R. A., and Chen, L. C., Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors: a population-based study, J Hypertens, 2018.
T. P. van Staa, Geusens, P., Bijlsma, J. W., Leufkens, H. G., and Cooper, C., Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis, Arthritis Rheum, vol. 54, pp. 3104-12, 2006.
A. Berger, Sadosky, A., Dukes, E., Edelsberg, J., and Oster, G., Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study, BMC Neurol, vol. 12, p. 8, 2012.
C. Miani, Martin, A., Exley, J., Doble, B., Wilson, E., Payne, R., Avery, A., Meads, C., Kirtley, A., Jones, M. M., and King, S., Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling, Health Technol Assess, vol. 21, pp. 1-128, 2017.
E. A. Shephard, Stapley, S., Neal, R. D., Rose, P., Walter, F. M., and Hamilton, W. T., Clinical features of bladder cancer in primary care, Br J Gen Pract, vol. 62, pp. e598-604, 2012.
S. A. Stapley, Rubin, G. P., Alsina, D., Shephard, E. A., Rutter, M. D., and Hamilton, W. T., Clinical features of bowel disease in patients aged <50 years in primary care: a large case-control study, Br J Gen Pract, vol. 67, pp. e336-e344, 2017.
[Page last reviewed 5 January 2021]